Mohan Pankaj 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
- Purchase
Common Stock
2023-03-15$0.58/sh+60,000$35,100→ 181,731 total
Holdings
- 570(indirect: By Children)
Common Stock
- 66,478(indirect: By Mohan Family Office)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.56 to $0.59 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]Includes unvested restricted stock units.
- [F3]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.